Fraud Risk and Heightened Scrutiny
The government's primary civil tool for addressing health care fraud is the False Claims Act (FCA). Most FCA cases are resolved through settlement agreements in which the government alleges fraudulent conduct and typically the settling parties do not admit liability. Depending on the facts and circumstances presented, OIG will usually pursue one of the following approaches when settling a health care fraud case: (1) exclusion; (2) heightened scrutiny; (3) integrity obligations; (4) take no further action; or (5) in the case of a good faith and cooperative self-disclosure, release 1128(b)(7) exclusion with no integrity obligations. OIG’s Risk Spectrum illustrates these approaches. For more information on how OIG evaluates risk to the Federal health care programs and the criteria the OIG considers in evaluating exclusions in False Claims Act cases, see OIG’s April 18, 2016 notice.
Risk Spectrum Category Links
- Exclusions Program
- List of Parties Under Heightened Scrutiny
- Corporate Integrity Agreements
- Self-Disclosure Information
![A graphic that shows high risk to low risk respectfully: Exclusion; Heightened Scrutiny; CIAs; No Further Action; Self-Disclosure](/media/images/spectrum_risk-spectrum.width-320.png)
FY 2024 Q1-Q4
![Fraud Risk Spectrum 2023 Q1: 17 exclusions, 2 heightened scrutiny, 29 CIAs, 184 no further action, 7 self-disclosure](/media/images/risk_spectrum-2023-q1-4.width-320.png)
![Fraud Risk Spectrum 2022 Q1-Q4: 11 exclusions, 1 heightened scrutiny, 37 CIAs, 193 no further action, 6 self-disclosure](/media/images/risk_spectrum-2022-q1-q4.width-320.jpg)
![Updated Risk Spectrum for 2021 Quarters 1 through 4](/media/images/risk_spectrum-2021-q1-q4_6dn8VMn.width-320.jpg)
![Updated Risk Spectrum for 2020 Quarters 1 through 4](/media/images/risk_spectrum-2020-q1-q4.width-320.jpg)
![Updated 2019 False Claims Act Settlements on the Risk Spectrum](/media/images/risk_spectrum-2019-q1-q4.width-320.jpg)
Last updated October 11, 2024